Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study

被引:2
|
作者
Ye, Wanlu [1 ]
Wang, Qing [1 ]
Lu, Yanming [1 ]
机构
[1] China Med Univ, Dept Obstet & Gynecol, Shengjing Hosp, Shenyang 110003, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Ovarian endometrioid carcinoma; SEER database; Nomogram; Prognosis; Treatment; CANCER; LYMPHADENECTOMY; WOMEN; RISK;
D O I
10.1007/s00432-023-05172-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundOvarian endometrioid carcinoma (OEC) is the second most commonly occurring ovarian epithelial malignancy, but the associated prognostic factors remain obscure. This study aimed to analyze independent prognostic factors for patients with OEC and to develop and validate a nomogram to predict the overall survival (OS) of these patients.MethodsClinical information of patients with OEC (2000-2019) was obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox analyses were used to identify independent prognostic factors, and nomogram models were constructed using independent prognostic factors. Receiver operating characteristic (ROC) curve, calibration plots, and decision curve analysis (DCA) were used to verify the accuracy and validity of the nomogram. Kaplan-Meier curves were used to compare the differences in OS and cancer-specific survival (CSS) among subgroups.ResultsA total of 4628 patients with OEC were included, being divided into training (n = 3238) and validation (n = 1390) sets (7:3 ratio). On multivariate Cox analysis, AJCC stage, age, tumor size, differentiation, chemotherapy, and lymph node resection were significant predictors of survival outcomes (P < 0.05). Resection of 1-3 lymph nodes in early-stage OEC patients did not significantly prolong OS (P > 0.05), but resection of & GE; 4 lymph nodes in early-stage improved OS and CSS (P < 0.05). The OS of early-stage patients was not related to whether or not they received chemotherapy (P > 0.05). Lymph node resection and chemotherapy significantly improved the prognosis of patients with advanced OEC (P < 0.05). The c-index of nomogram prediction model was 0.782. ROC with good discrimination, calibration plots with high consistency, and DCA with large net benefit rate result in large clinical value.ConclusionAJCC stage, differentiation, tumor size, age, chemotherapy, and lymph node dissection were prognostic factors of OEC. The constructed nomogram prediction model can effectively predict the prognosis of OEC patients and improve the accuracy of clinical decision-making.
引用
收藏
页码:13607 / 13618
页数:12
相关论文
共 50 条
  • [1] Construction and validation of prognostic nomogram and clinical characteristics for ovarian endometrioid carcinoma: an SEER-based cohort study
    Wanlu Ye
    Qing Wang
    Yanming Lu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13607 - 13618
  • [2] Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study
    Lu, Zhaoxiang
    He, Wei
    Zhou, Jun
    Yang, Cheng
    Xiang, Rong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (06)
  • [3] Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study
    Hou, Guangdong
    Li, Xi'an
    Zheng, Yu
    Liu, Pengfei
    Yan, Fei
    Ju, Dongen
    Zhang, Geng
    Zheng, Wanxiang
    Gao, Ming
    Hou, Niuniu
    Yuan, Jiarui
    Wang, Fuli
    Yuan, Jianlin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (07) : 1356 - 1363
  • [4] Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study
    Guangdong Hou
    Xi’an Li
    Yu Zheng
    Pengfei Liu
    Fei Yan
    Dongen Ju
    Geng Zhang
    Wanxiang Zheng
    Ming Gao
    Niuniu Hou
    Jiarui Yuan
    Fuli Wang
    Jianlin Yuan
    International Journal of Clinical Oncology, 2020, 25 : 1356 - 1363
  • [5] Construction and validation of a nomogram for patients with multiple hepatocellular carcinoma: A SEER-based study
    Shen, Jie
    Zhou, Yu
    Yu, Bin
    Zhao, Kailiang
    Ding, Youming
    EJSO, 2023, 49 (10):
  • [6] Development and validation of a prognostic nomogram for Hurthle cell thyroid carcinoma: a SEER-based study
    Shen, Cong
    Zhao, Yunzhe
    Qiu, Xiangyuan
    Li, Peng
    Ding, Ying
    Wang, Wenlong
    Sun, Botao
    Li, Xinying
    Jiang, Wei
    GLAND SURGERY, 2022, 11 (03) : 535 - 544
  • [7] Development and validation of a prognostic nomogram for patients with ganglioneuroblastoma: A SEER-based study
    Li, Weiyu
    Ou, Zhaoxing
    Wu, Zhanghai
    Li, Liujun
    Ye, Feile
    Wen, Xin
    Ye, Dalin
    HELIYON, 2024, 10 (09)
  • [8] Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma
    Yang, Renyi
    Yu, Xiaopeng
    Zeng, Puhua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10099 - 10108
  • [9] Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma
    Renyi Yang
    Xiaopeng Yu
    Puhua Zeng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10099 - 10108
  • [10] Development and validation of a prognostic nomogram for ovarian clear cell carcinoma: a study based on the SEER database and a Chinese cohort
    Yao Shen
    Fei Xi
    Pingge Zhao
    Yuhang Zhang
    Guanlin Guo
    Xueyuan Jia
    Jie Wu
    Ye Kuang
    Discover Oncology, 16 (1)